DNA logo

DNA
Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

12,669
Mkt Cap
$389.01M
Volume
567,447.00
52W High
$17.58
52W Low
$5.00
PE Ratio
-1.12
DNA Fundamentals
Price
$6.69
Prev Close
$6.34
Open
$6.36
50D MA
$8.82
Beta
2.62
Avg. Volume
1.31M
EPS (Annual)
-$5.64
P/B
0.69
Rev/Employee
$350,835.05
$471.09
Loading...
Loading...
News
all
press releases
Ginkgo Bioworks (NYSE:DNA) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen upgraded shares of Ginkgo Bioworks from a "sell" rating to a "hold" rating in a report on Sunday...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure
Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure PR Newswire BOSTON, March 2...
PR Newswire·9d ago
News Placeholder
Ginkgo Bioworks Q4 Earnings Call Highlights
Ginkgo Bioworks (NYSE:DNA) used its fourth-quarter earnings call to outline a sharpened strategic focus for 2026 centered on autonomous labs, while also detailing year-over-year declines in cell...
MarketBeat·12d ago
News Placeholder
Erste Asset Management GmbH Acquires 200,000 Shares of Ginkgo Bioworks Holdings, Inc. $DNA
Erste Asset Management GmbH lifted its holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Free Report) by 10.0% in the third quarter, according to the company in its most recent filing with the...
MarketBeat·12d ago
News Placeholder
Ginkgo Bioworks (NYSE:DNA) Releases Quarterly Earnings Results, Beats Estimates By $0.38 EPS
Ginkgo Bioworks (NYSE:DNA - Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($1.42) earnings per share (EPS) for the quarter, beating the consensus estimate...
MarketBeat·13d ago
News Placeholder
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business Ginkgo Bioworks Reports...
PR Newswire·13d ago
News Placeholder
Insights into Ginkgo Bioworks Holdings's Upcoming Earnings
read more...
Benzinga·14d ago
News Placeholder
Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation
Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation PR Newswire BOSTON...
PR Newswire·20d ago
News Placeholder
Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-based Agricultural Products
Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-based Agricultural Products Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop...
PR Newswire·21d ago
News Placeholder
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts
The latest trading day saw Ginkgo Bioworks Holdings, Inc. (DNA) settling at $9, representing a -3.12% change from its previous close.
Zacks·22d ago
<
1
2
...
>

Latest DNA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.